Coalition Urges Policymakers to Reject No Surprises Act Enforcement Bill
The Coalition Against Surprise Medical Billing launched a campaign opposing the No Surprises Act Enforcement Act, arguing it would worsen IDR process abuse.
After Antibiotic Approval, Spero Pivots to Immunology Aiming to Rival an Amgen Asset
Spero Therapeutics enters immunology with an antibody licensed from Innovent Biologics. The lead indication is a rare autoimmune condition where Spero aims to offer advantages over the Amgen drug that is currently the only approved treatment.
Why the Next Era of Sleep Medicine Depends on Better Diagnostics
Matching the right patient to the right therapy now requires understanding what’s driving the apnea, not just how often it occurs. Closing that gap means rethinking what sleep apnea testing identifies and where it happens.
Revenue Is a Misleading KPI in Healthcare
It usually tracks some version of value delivered, where more customers lead to more usage and more revenue. However, in healthcare, the blind pursuit of revenue can cause real harm.
Pharmacy Benefit Operations Infrastructure Must Rise to Regulatory Reform Standards
The PBM reform efforts are directional, not temporary. Meeting these expectations requires automated systems that can reconstruct claim logic on demand and provide real-time alignment between pricing, rebates and financial outputs.